Mobocertinib
CAS: 1847461-43-1
Ref. 3D-XYC46143
2mg | 138,00 € | ||
5mg | 194,00 € | ||
10mg | 310,00 € | ||
25mg | 472,00 € | ||
50mg | 646,00 € |
Información del producto
Mobocertinib is an anti-cancer drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its activity. It is used in the treatment of solid tumours, including those that are resistant to platinum-based chemotherapy. Mobocertinib has been shown to be potent against a range of cancers, both pediatric and adult, including cancer tissues from urothelial carcinoma, PD-L1 positive non-small cell lung cancer (NSCLC), and NSCLC with pd-l1 negative status. Using LC-MS/MS, the pharmacokinetics of mobocertinib have been determined in human plasma. The drug binds tightly to plasma proteins such as albumin and alpha 1 acid glycoprotein (AAG). Mobocertinib is metabolized by CYP3A4 and CYP3A5 into active metabolites.
Propiedades químicas
Consulta técnica sobre: 3D-XYC46143 Mobocertinib
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.